Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

09-Sep-19 - 06-Sep-20
Buy Ratio:35%


# Net Buyers:91
# Net Sellers:170

Previous 52 Weeks

10-Sep-18 - 08-Sep-19
Buy Ratio:38%
# Net Buyers:111
# Net Sellers:182
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.--$3.37B  
Loxo Oncology, Inc.--$576.60M  
Aimmune Therapeutics, Inc.$290.03M$291.42M  
Osiris Therapeutics, Inc.--$281.65M  
Spark Therapeutics, Inc.--$256.00M  
New Net Buyers
CompanyNet Buy AmountChange
Aimmune Therapeutics, Inc.$290.03M$291.42M  
Merck & Co., Inc.$3.50M$190.46M  
Vertex Pharmaceuticals Inc / Ma$4.55M$121.56M  
Alexion Pharmaceuticals, Inc.$33.44M$77.65M  
Fate Therapeutics Inc$51.81M$77.39M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Regeneron Pharmaceuticals, Inc.($1.29B)($1.04B)  
Seagen Inc.($557.93M)($526.97M)  
Eli Lilly & Co($782.79M)($434.27M)  
Vaxart, Inc.($317.86M)($317.86M)  
Corium International, Inc.--($299.40M)  
New Net Sellers
CompanyNet Buy AmountChange
Aerie Pharmaceuticals Inc($17.67M)($32.29M)  
Acceleron Pharma Inc($4.04M)($29.24M)  
Xbiotech Inc.($10.11M)($20.34M)  
Alpine Immune Sciences, Inc.($139.90K)($20.07M)  
Molecular Templates, Inc.($4.99M)($10.08M)